C-reactive protein is elevated in atypical but not nonatypical depression: Data from the National Health and Nutrition Examination Survey (NHANES) 1999-2004

Journal of Behavioral Medicine

Volumn 37, Issue 4, 2014, Pages 621-629

  Hickman, Ruth J ^b   Khambaty, Tasneem ^a   Stewart, Jesse C ^a  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atypical depression; C reactive protein; Inflammation; Major depressive disorder; NHANES

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; BLOOD; CASE CONTROL STUDY; CLASSIFICATION; COMPLICATION; CORONARY ARTERY DISEASE; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMAN; MALE; METABOLISM; NUTRITION; RISK FACTOR; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; NUTRITION SURVEYS; RISK FACTORS; YOUNG ADULT;

EID: 84905097590     PISSN: 01607715     EISSN: 15733521     Source Type: Journal    
DOI: 10.1007/s10865-013-9510-0     Document Type: Article

References (61)

1. Abi-Saleh, B., Iskandar, S. B., Elgharib, N., & Cohen, M. V. (2008). C-reactive protein: The harbinger of cardiovascular diseases. Southern Medical Journal, 101, 525-533.
2. Abraham, G., Sundaram, V., Sundaram, V., Mathew, M., Leslie, N., & Sathiah, V. (2009). C-reactive protein, a valuable predictive marker in chronic kidney disease. Saudi Journal of Kidney Disease and Transplantation, 20, 811-815.
3. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders: DSM-IV (4th ed.). Washington: American Psychiatric Association.
4. Bankier, B., Barajas, J., Martinez-Rumayor, A., & Januzzi, J. (2009). Association between anxiety and C-reactive protein levels in stable coronary heart disease patients. Psychosomatics, 50, 347-353.
5. Blanco, C., Vesga-López, O., Stewart, J., Liu, S., Grant, B., & Hasin, D. (2011). Epidemiology of major depression with atypical features: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Journal of Clinical Psychiatry, 73, 224-232.
6. Carney, R., Freedland, K. E., & Veith, R. C. (2005). Depression, the autonomic nervous system, and coronary heart disease. Psychosomatic Medicine, 67, S29-S33.
7. DeCarlo, L. T. (1997). On the meaning and use of kurtosis. Psychological Methods, 2, 292-307.
8. Deverts, D. J., Cohen, S., Dilillo, V. G., Lewis, C. E., Kiefe, C., Whooley, M., et al. (2010). Depressive symptoms, race, and circulating C-reactive protein: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Psychosomatic Medicine, 72, 734-741.
9. Everson, S. A., Goldberg, D. E., Kaplan, G. A., Cohen, R. D., Pukkala, E., Tuomilehto, J., et al. (1996). Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosomatic Medicine, 58, 113-121.
10. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (2002). Structured clinical interview for DSM-IV-TR Axis I disorders, research version, non-patient edition (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute.
11. Gimeno, D., Kivimäkia, M., Brunner, E. J., Elovainio, M., De Vogli, R., Steptoe, A., et al. (2009). Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychological Medicine, 39, 413-423.
12. Gold, P. W., & Chorousos, G. P. (2002). Organization of the stress system and its dysregulation in melancholic and atypical depression: High vs low CRH/NE states. Molecular Psychiatry, 7, 254-275.
13. Grippo, A. J., & Johnson, A. K. (2002). Biological mechanisms in the relationship between depression and heart disease. Neuroscience and Biobehavioral Reviews, 26, 941-962.
14. Hackam, D. G., & Anand, S. S. (2003). Emerging risk factors for atherosclerotic vascluar disease: A critical review of the evidence. The Journal of the American Medical Association, 290, 932-940.
15. Hamer, M., Molloy, G. J., de Oliveira, C., & Demakakos, P. (2009). Persistent depressive symptomatology and inflammation: To what extent do health behaviors and weight control mediate this relationship? Brain, Behavior, and Immunity, 23, 413-418.
16. Hamer, M., Sabia, S., Batty, G., Shipley, M., Tabák, A., Singh-Manoux, A., et al. (2012). Physical activity and inflammatory markers over 10 years: Follow-up in men and women from the Whitehall II Cohort Study. Circulation, 126, 928-933.
17. Haro, J. M., Arbabzadeh-Bouchez, S., Brugha, T. S., De Girolamo, G., Guyer, M. E., Jin, R., et al. (2006). Concordance of the composite international diagnostic interview version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. International Journal of Methods in Psychiatric Research, 15, 167-180.
18. Herrán, A., Sierra-Biddle, D., García-Unzueta, M., Puente, J., Vázquez-Barquero, J., & Antonio Amado, J. (2005). The acute phase response in panic disorder. International Journal of Neuropsychopharmacology, 8, 529-535.
19. Horwath, E., Johnson, J., Weissman, M. M., & Hornig, C. D. (1992). The validity of major depression with atypical features based on a community study. Journal of Affective Disorders, 26, 117-125.
20. Howren, M. B., Lamkin, D. M., & Suls, J. (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosomatic Medicine, 71, 171-186.
21. Joynt, K., Whellan, D. J., & O'Connor, C. M. (2003). Depression and cardiovascular disease: Mechanisms of interaction. Biological Psychiatry, 54, 248-261.
22. Karlović, D., Serretti, A., Vrkic, N., Martinac, M., & Marcinko, D. (2012). Serum concentrations of CRP, IL-6, and TNF-α, and cortisol in major depressive disorder with melancholic or atypical features. Psychiatry Research. doi: 10.1016/j.psychres.2011.12.007
23. Kendler, K. S. (1996). Major depression and generalised anxiety disorder. Same genes (partly) different environments - Revisited. The British Journal of Psychiatry Supplement, 30, 68-75.
24. Kerner, A., Avizohar, O., Sella, R., Bartha, P., Zinder, O., Markiewicz, W., et al. (2005). Association between elevated liver enzymes and C-reactive protein: Possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 193-197.
25. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., et al. (2003). The epidemiology of major derpessive disorder: Results from the National Comorbidity Survey Replication (NCS-R). The Journal of the American Medical Association, 289, 3095-3105.
26. Kline, R. B. (2005). Principles and practice of structural equation modeling (2nd ed.). New York: The Guilford Press.
27. Kop, W. J., & Gottdiener, J. S. (2005). The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosomatic Medicine, 67, S37-S41.
28. Kubzansky, L. D., Sparrow, D., Vokonas, P., & Kawachi, I. (2001). Is the glass half empty or half full? A prospective study of optimism and coronary heart disease in the normative aging study. Psychosomatic Medicine, 63, 910-916.
29. Levitan, R. D., Lesage, A., Parikh, S. V., Goergin, P., & Kennedy, S. H. (1997). Reveresed neurovegetative symptoms of depression: A community study of Ontario. American Journal of Psychiatry, 154, 934-940.
30. Liukkonen, T., Räsänen, P., Jokelainen, J., Leinonen, M., Järvelin, M. R., Meyer-Rochow, V. B., et al. (2011). The association between anxiety and C-reactive protein (CRP) levels: Results from the Northern Finland 1966 birth cohort study. European Psychiatry, 26, 363-369.
31. Matthews, K. A., Raikkonen, K., Sutton-Tyrrell, K., & Kuller, L. H. (2004). Optimistic attitudes protect against progression of carotid atherosclerosis in healthy middle-aged women. Psychosomatic Medicine, 66, 640-644.
32. Matza, L. S., Revicki, D. A., Davidson, J. R., & Stewart, J. W. (2003). Depression with atypical features in the National Comorbidity Survey: Classification, description, and consequences. Archives of General Psychiatry, 60, 817-826.
33. Miller, G. E., Cohen, S., & Ritchey, A. K. (2002). Chronic psychological stress and the regulation of pro-inflammatory cytokines: A glucocorticoid-resistance model. Health Psychology, 21, 531-541.
34. Miller, G. E., Freedland, K., Carney, R., Stetler, C., & Banks, W. (2003). Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain, Behavior, and Immunity, 17, 276-285.
35. National Center for Health Statistics. (2000). National Health and Nutrition Examination Survey. Laboratory procedures manual: C-reactive protein. Hyattsville, MD: National Center for Health Statistics. Retrieved August 29, 2012 from http://www.cdc.gov/nchs/data/nhanes/nhanes-03-04/l11-c-met-c-reactive- protein.pdf.
36. National Center for Health Statistics. (2001). National Health and Nutrition Examination Survey. Interviewer Procedures Manual. Hyattsville, MD: National Center for Health Statistics. Retrieved September 3, 2012 from http://www.cdc.gov/nchs/data/nhanes/nhanes-09-10/MECInterviewers.pdf.
37. National Center for Health Statistics. (2004). National Health and Nutrition Examination Survey. Analytic guidelines. Hyattssville, MD: National Center for Health Statistics. Retrieved September 2, 2012 from http://www.cdc.gov/nchs/data/nhanes/nhanes-general-guidelines-june-04.pdf.
38. National Center for Health Statistics. (2006). National Health and Nutrition Examination Survey. 2001-2002 data documentation, codebook, and frequencies: Composite international diagnostic interview. Hyattssville, MD: National Center for Health Statistics. Retrieved September 2, 2012 from http://www.cdc.gov/nchs/nhanes/nhanes2001-2002/CIQGAD-B.htm.
39. Nicholson, A., Kuper, H., & Hemingway, H. (2006). Depresion as an aetiologc and prognostic factor in coronary heart disease: A meta-analysis of 6362 events amont 146,538 participants in 54 observational studies. European Heart Journal, 27, 2763-2774.
40. Omori, H., Tsuji, M., Sata, K., Iyonaga, C., Narimatsu, A., Mihara, S., et al. (2009). Correlation of C-reactive protein with disease severity in CT diagnosed emphysema. Respirology, 14, 551-558.
41. Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., et al. (2003). Markers of inflammation and cardiovascular disease. Circulation, 107, 499-511.
42. Quitkin, F. M. (2002). Depression with atypical features: Diagnostic validity, prevalence, and treatment. Primary Care Companion to the Journal of Clinical Psychiatry, 4, 94-99.
43. Raison, C. L., Capuron, L., & Miller, A. H. (2006). Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends in Immunology, 27, 24-31.
44. Rhen, T., & Cidlowski, J. (2005). Antiinflammatory actions of glucocorticoids - New mechanisms for old drugs. New England Journal of Medicine, 353, 1711-1723.
45. Rothermundt, M., Arolt, V., Peters, M., Gutbrodt, H., Fenker, J., Kersting, A., et al. (2001). Inflammatory markers in major depression and melancholia. Journal Affective Disorders, 63, 93-102.
46. Scrandis, D. A., Langenberg, P., Tonelli, L. H., Sheikh, T. M., Manogura, A. C., Alberico, L. A., et al. (2008). Prepartum depressive symptoms correlate positively with C-reactive protein levels and negatively with tryptophan levels: A preliminary report. International Journal of Child Health and Human Development, 1, 167-174.
47. Singh, T., & Williams, K. (2006). Atypical depression. Psychiatry (Edgmont), 3, 33-39.
48. Sokka, T., & Pincus, T. (2009). Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid athritis seen between 1980 and 2004: Analyses from Finland and the United States. Journal of Rheumatology, 36, 1387-1390.
49. Spath-Schwalbe, E., Hansen, K., Schmidt, F., Schrezenmeier, H., Marshall, L., Burger, K., et al. (1998). Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. Journal of Clinical Endocrinology and Metabolism, 83, 1573-1579.
50. Stewart, J. C., Janicki, D. L., Muldoon, M. F., Sutton-Tyrell, K., & Kamarck, T. W. (2007). Negative emotions and 3-year progression of subclinical arthrosclerosis. Archives of General Psychiatry, 64, 225-233.
51. Stewart, J. C., Rand, K. L., Muldoon, M. F., & Kamarck, T. W. (2009). A prospective evaluation of the directionality of the depression-inflammation relationship. Brain, Behavior, and Immunity, 23, 936-944.
52. Stewart, J. C., Zielke, D. J., Hawkins, M. A., Williams, D. R., Carnethon, M. R., Knox, S. S., et al. (2012). Depressive symptom clusters and 5-year incidence of coronary artery calcification: The cardia study. Circulation, 126, 410-417.
53. Ströhle, A. (2009). Physical activity, exercise, depression and anxiety disorders. Journal of Neural Transmission, 116, 774-784.
54. Sullivan, P. F., Kessler, R. C., & Kendler, K. S. (1998). Latent class analysis of lifetime depressive symptoms in the national comorbidity survey. American Journal of Psychiatry, 155, 1398-1406.
55. Suls, J., & Bunde, J. (2005). Anger, anxiety, and depression as risk factors for cardiovascular disease: The problems and implications of overlapping affective dispositions. Psychological Bulletin, 131, 260-300.
56. Tracey, K. J. (2002). The inflammatory reflex. Nature, 420, 853-859.
57. van den Biggelaar, A. H., Gussekloo, J., de Craen, A. J., Frolich, M., Stek, M. L., van der Mast, R. C., et al. (2007). Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Experimental Gerontology, 42, 693-701.
58. Van der Kooy, K., Van Hout, H., Marwijk, H., Marten, H., Stewhouwer, C., & Beekman, A. (2007). Depression and the risk for cardiovascular diseases: Systemic review and meta analysis. International Journal of Geriatric Psychiatry, 22, 613-626.
59. Wander, K., Brindle, E., & O'Connor, K. A. (2008). C-reactive protein across the menstrual cycle. American Journal of Physical Anthropology, 136, 138-146.
60. Wichers, M., & Maes, M. (2002). The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. International Journal of Neuropsychopharmacology, 5, 375-388.
61. World Health Organization. (1993). The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research. Geneva: World Health Organization.